Overexpression of NF-kB as a predictor of neoadjuvant chemotherapy response in breast cancer

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Human epidermal growth factor receptor 2 status of breast cancer patients in Asia: Results from a large, multicountry study

(2016) Nirmala Pathmanathan et al.   Asia-Pacific Journal of Clinical Oncology

Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients

(2013) M. J. Engstrøm et al.   BREAST CANCER RESEARCH AND TREATMENT

Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up

(2013) Xuehong Zhang et al.   BREAST CANCER RESEARCH AND TREATMENT

HER2 and response to anthracycline-based neoadjuvant chemotherapy in breast cancer

(2011) L. Yao et al.   ANNALS OF ONCOLOGY

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Apoptosis in cancer: from pathogenesis to treatment

(2011) Rebecca SY Wong   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Her2 activates NF-κB and induces invasion through the canonical pathway involving IKKα

(2009) E C Merkhofer et al.   ONCOGENE